Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activityMore than 300,000 people in the U.S.

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Once again, Dupixent finished in second place with an impressions SOV of 5.40% and 2.8 billion impressions. Notably, the ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...

WNBA legend and all-time scoring leader Diana Taurasi shows she' passionate about off-court causes involving health and wellbeing.

The exact causes of both eczema and asthma are not known. However, both conditions lead to excess inflammation in your body. Eczema is a group of skin conditions that cause redness, pain, itching, ...

Hives and eczema both involve itchy skin rashes and are related to allergies. While they may share some similarities, these two conditions are distinct in their symptoms, underlying causes, and ...

U.S. drugmaker Regeneron Pharmaceuticals beat Wall Street estimates for third-quarter profit and revenue on Thursday, driven ...

Another, EVO301, could reach Phase 2 testing in a common type of eczema in 2025 as well ... among them Celldex’s barzovolimab and Sanofi and Regeneron’s Dupixent, are administered via infusion or ...